PCN23 COST-EFFECTIVENESS ANALYSIS OF LAPATINIB PLUS CAPECITABINE VERSUS CAPECITABINE ALONE IN THE SECOND LINE TREATMENT FOR BREAST CANCER TREATMENT
May 1, 2008, 00:00
10.1016/S1098-3015(10)70201-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)70201-1/fulltext
Title :
PCN23 COST-EFFECTIVENESS ANALYSIS OF LAPATINIB PLUS CAPECITABINE VERSUS CAPECITABINE ALONE IN THE SECOND LINE TREATMENT FOR BREAST CANCER TREATMENT
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70201-1&doi=10.1016/S1098-3015(10)70201-1
First page :
Section Title :
Open access? :
No
Section Order :
849